JP2025102783A5 - - Google Patents

Info

Publication number
JP2025102783A5
JP2025102783A5 JP2025034621A JP2025034621A JP2025102783A5 JP 2025102783 A5 JP2025102783 A5 JP 2025102783A5 JP 2025034621 A JP2025034621 A JP 2025034621A JP 2025034621 A JP2025034621 A JP 2025034621A JP 2025102783 A5 JP2025102783 A5 JP 2025102783A5
Authority
JP
Japan
Prior art keywords
promoter
nucleic acid
sequence
acid according
polyadenylation signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025034621A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025102783A (ja
Filing date
Publication date
Priority claimed from JP2021529002A external-priority patent/JP7704998B2/ja
Application filed filed Critical
Publication of JP2025102783A publication Critical patent/JP2025102783A/ja
Publication of JP2025102783A5 publication Critical patent/JP2025102783A5/ja
Pending legal-status Critical Current

Links

JP2025034621A 2018-11-21 2025-03-05 組換えウイルスベクター及びそれの産生のための核酸 Pending JP2025102783A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862770202P 2018-11-21 2018-11-21
US62/770,202 2018-11-21
JP2021529002A JP7704998B2 (ja) 2018-11-21 2019-11-21 組換えウイルスベクター及びそれの産生のための核酸
PCT/US2019/062531 WO2020106916A1 (en) 2018-11-21 2019-11-21 Recombinant viral vectors and nucleic acids for producing the same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021529002A Division JP7704998B2 (ja) 2018-11-21 2019-11-21 組換えウイルスベクター及びそれの産生のための核酸

Publications (2)

Publication Number Publication Date
JP2025102783A JP2025102783A (ja) 2025-07-08
JP2025102783A5 true JP2025102783A5 (cg-RX-API-DMAC7.html) 2026-04-30

Family

ID=70773595

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021529002A Active JP7704998B2 (ja) 2018-11-21 2019-11-21 組換えウイルスベクター及びそれの産生のための核酸
JP2025034621A Pending JP2025102783A (ja) 2018-11-21 2025-03-05 組換えウイルスベクター及びそれの産生のための核酸

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021529002A Active JP7704998B2 (ja) 2018-11-21 2019-11-21 組換えウイルスベクター及びそれの産生のための核酸

Country Status (20)

Country Link
US (1) US20210324418A1 (cg-RX-API-DMAC7.html)
EP (1) EP3883954A4 (cg-RX-API-DMAC7.html)
JP (2) JP7704998B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210103469A (cg-RX-API-DMAC7.html)
CN (1) CN113302201A (cg-RX-API-DMAC7.html)
AR (1) AR117145A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019385506A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021009733A2 (cg-RX-API-DMAC7.html)
CA (1) CA3120289A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021001327A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021008120A2 (cg-RX-API-DMAC7.html)
EA (1) EA202191418A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP21044840A (cg-RX-API-DMAC7.html)
IL (1) IL283344A (cg-RX-API-DMAC7.html)
MX (1) MX2021005997A (cg-RX-API-DMAC7.html)
PE (1) PE20211419A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021551155A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202105326WA (cg-RX-API-DMAC7.html)
TW (1) TW202039533A (cg-RX-API-DMAC7.html)
WO (1) WO2020106916A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107686842A (zh) * 2016-08-03 2018-02-13 南京大学 一种靶多核苷酸编辑方法及其应用
US12509492B2 (en) 2018-01-19 2025-12-30 Duke University Genome engineering with CRISPR-Cas systems in eukaryotes
BR112020020266A2 (pt) 2018-04-03 2021-01-19 Stridebio, Inc. Vetores de vírus com evasão de anticorpos
MX2020010465A (es) 2018-04-03 2021-01-08 Vectores de virus para direccionamiento a tejidos oftalmicos.
CA3095179A1 (en) 2018-04-03 2019-10-10 Stridebio, Inc. Antibody-evading virus vectors
CN113727992A (zh) 2019-03-21 2021-11-30 斯特里迪比奥公司 重组腺相关病毒载体
TWI887234B (zh) 2019-04-14 2025-06-21 美國公爵大學 治療杜興氏(duchenne)肌肉失養症之大型突變熱點之aav載體介導之刪除
MX2022004353A (es) 2019-10-17 2022-07-19 Casete de transferencia de aav.
CN114787180A (zh) 2019-10-17 2022-07-22 斯特里迪比奥公司 用于治疗c型尼曼-匹克病的腺相关病毒载体
US12173304B2 (en) 2020-07-08 2024-12-24 Neuracle Genetics Inc. Intron fragments
US20230285596A1 (en) * 2020-07-27 2023-09-14 Voyager Therapeutics, Inc Compositions and methods for the treatment of niemann-pick type c1 disease
JP2023542614A (ja) * 2020-08-19 2023-10-11 サレプタ セラピューティクス, インコーポレイテッド レット症候群の治療のためのアデノ随伴ウイルスベクター
EP4221761A4 (en) * 2020-09-29 2025-02-26 Neuexcell Therapeutics Inc. Neurod1 combination vector
WO2022072309A1 (en) * 2020-09-29 2022-04-07 NeuExcell Therapeutics Inc. Ascl1 vector
MX2023003655A (es) * 2020-09-29 2023-06-22 Neuexcell Therapeutics Inc Vector neurod1.
CA3197320A1 (en) * 2020-09-29 2022-04-07 NeuExcell Therapeutics Inc. Dlx2 vector
WO2022087321A1 (en) * 2020-10-21 2022-04-28 Duke University Dual aav vector-mediated deletion of large mutational hotspot for treatment of duchenne muscular dystrophy
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
US20240058477A1 (en) * 2021-01-04 2024-02-22 University Of Florida Research Foundation, Incorporated Methods and compositions for treatment of friedreich's ataxia
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
MX2024003241A (es) * 2021-09-17 2024-05-15 Astellas Gene Therapies Inc Terapia genica con frataxina.
CN119213133B (zh) 2022-05-16 2026-01-06 上海天泽云泰生物医药有限公司 用于治疗i型戊二酸尿症的重组aav载体
EP4536286A1 (en) * 2022-06-08 2025-04-16 Scribe Therapeutics Inc. Aav vectors for gene editing
EP4598590A4 (en) * 2022-10-08 2026-05-27 Lingyi Biotech Co Ltd CONSTRUCTION TO IMPROVE GENE EXPRESSION
WO2024163678A2 (en) * 2023-02-01 2024-08-08 Tune Therapeutics, Inc. Fusion proteins and systems for targeted activation of frataxin (fxn) and related methods
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
AU2024393766A1 (en) 2023-12-08 2026-06-18 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems
CN117701638B (zh) * 2023-12-18 2024-10-18 苏州新芽基因生物技术有限公司 一种抑制残留aav载体质粒和质粒骨架转录活性的方法
WO2026019230A1 (ko) * 2024-07-15 2026-01-22 삼성바이오에피스 주식회사 스터퍼를 포함하는 재조합 aav 생산을 위한 벡터 시스템

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002254529A1 (en) * 2001-04-04 2002-10-21 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Nucleic acids for transgene expression
US20090221620A1 (en) * 2008-02-20 2009-09-03 Celera Corporation Gentic polymorphisms associated with stroke, methods of detection and uses thereof
DK2986635T3 (en) * 2013-04-18 2019-01-28 Fond Telethon EFFECTIVE DELIVERY OF BIG GENES THROUGH DUAL-AAV VECTORS
US20160256571A1 (en) * 2013-09-30 2016-09-08 Sanofi Invention
US10947596B2 (en) 2014-05-06 2021-03-16 Dana-Farber Cancer Institute, Inc. Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators
US11697825B2 (en) * 2014-12-12 2023-07-11 Voyager Therapeutics, Inc. Compositions and methods for the production of scAAV
EP3632923A1 (en) 2015-01-16 2020-04-08 Voyager Therapeutics, Inc. Central nervous system targeting polynucleotides
CA3255657A1 (en) * 2015-02-10 2025-12-01 Genzyme Corporation VARIANT RNAi
WO2016150964A1 (en) * 2015-03-23 2016-09-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with friedreich ataxia
EP3280451B8 (en) * 2015-04-08 2019-09-25 The United States of America, as represented by the Secretary, Department of Health and Human Services Viral gene therapy as treatment for cholesterol storage disease or disorder
PL3298134T3 (pl) * 2015-05-16 2023-09-18 Genzyme Corporation Edycja genów mutacji głęboko intronowych
EP4378487A3 (en) * 2015-06-23 2024-09-04 The Children's Hospital of Philadelphia Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
WO2017023708A1 (en) * 2015-07-31 2017-02-09 California Institute Of Technology Activity-dependent expression of nucleic acids
SG10201912763QA (en) * 2015-11-05 2020-02-27 Bamboo Therapeutics Inc Modified friedreich ataxia genes and vectors for gene therapy
SG10201912935WA (en) * 2015-12-15 2020-02-27 Genzyme Corp Adeno-associated viral vectors for treating mucolipidosis type ii
CA3029119A1 (en) * 2016-06-29 2018-01-04 Crispr Therapeutics Ag Materials and methods for treatment of friedreich ataxia and other related disorders
US20200056206A1 (en) * 2016-12-01 2020-02-20 UNIVERSITé LAVAL Crispr-based treatment of friedreich ataxia
US20210254056A1 (en) * 2017-05-05 2021-08-19 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
MX2020003042A (es) * 2017-09-29 2020-11-18 Voyager Therapeutics Inc Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.

Similar Documents

Publication Publication Date Title
JP7707261B2 (ja) 筋疾患の治療のための改変aavカプシドポリペプチド
KR20210103469A (ko) 재조합 바이러스 벡터 및 이를 생산하기 위한 핵산
JP7433360B2 (ja) Pah遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法
US6479654B1 (en) Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
ES2646716T3 (es) Oligonucleótidos antisentido para el tratamiento de amaurosis congénita de Leber
JP6023073B2 (ja) ムコ多糖症におけるcns病変を処置するための治療戦略
AU2018202783A1 (en) Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
CN110325199A (zh) 用于治疗苯丙酮尿症的基因疗法
AU2016267687B2 (en) Adeno-associated virus mediated delivery of C1EI as a therapy for angioedema
JP2022520232A (ja) ダノン病の治療のための遺伝子療法ベクター
US20250041448A1 (en) Gene Therapy of Fibroblast Growth Factor 23 Related Hypophosphatemic Diseases
KR20230003477A (ko) 비-바이러스성 dna 벡터 및 인자 ix 치료제 발현을 위한 이의 용도
CN108025047B (zh) 腺相关病毒介导的c1ei递送作为用于血管性水肿的疗法
US20230295658A1 (en) Compositions and methods for in vivo gene transfer
KR20240005950A (ko) 벡터 시스템
AU2002226400A1 (en) Sequences upstream of the carp gene, vectors containing them and uses thereof
EP1358208A2 (en) Sequences upstream of the carp gene, vectors containing them and uses thereof
CN120129750A (zh) 用于目的基因的表达盒及其应用
AU2004200697A1 (en) Variants of the Angiogenic Factor Vascular Endothelial Cell Growth Factor: VEGF